Alethiomics Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 9

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $7.99M

  • Investors
  • 3

Alethiomics General Information

Description

Operator of a pre-clinical biotech company intended to develop targeted therapies to treat a family of blood cancers. The company uses single-cell multi-omic technology to discover curative therapies and treatments, enabling medical professionals to provide treatments for myeloproliferative neoplasms that begin with mutations occurring in cancer stem cells in the bone marrow.

Contact Information

Website
www.alethiomics.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Innovation building, Old Road Campus
  • Roosevelt Drive
  • Oxford OX3 7FZ
  • England, United Kingdom
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
HealthTech, Life Sciences, Oncology
Corporate Office
  • Innovation building, Old Road Campus
  • Roosevelt Drive
  • Oxford OX3 7FZ
  • England, United Kingdom

Alethiomics Timeline

2022202320242025
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Alethiomics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 15-Dec-2021 $7.99M Completed Generating Revenue
1. University Spin-Out 13-Jul-2021 Completed Generating Revenue
To view Alethiomics’s complete valuation and funding history, request access »

Alethiomics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Preferred Seed
To view Alethiomics’s complete cap table history, request access »

Alethiomics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Alethiomics Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Cancer Research Horizons Venture Capital Minority
Oxford Science Enterprises Venture Capital Minority
University of Oxford University
To view Alethiomics’s complete investors history, request access »

Ready to get started?

Request a free trial

Alethiomics FAQs

  • When was Alethiomics founded?

    Alethiomics was founded in 2021.

  • Where is Alethiomics headquartered?

    Alethiomics is headquartered in Oxford, United Kingdom.

  • What is the size of Alethiomics?

    Alethiomics has 9 total employees.

  • What industry is Alethiomics in?

    Alethiomics’s primary industry is Drug Discovery.

  • Is Alethiomics a private or public company?

    Alethiomics is a Private company.

  • What is the current valuation of Alethiomics?

    The current valuation of Alethiomics is .

  • What is Alethiomics’s current revenue?

    The current revenue for Alethiomics is .

  • How much funding has Alethiomics raised over time?

    Alethiomics has raised $7.99M.

  • Who are Alethiomics’s investors?

    Cancer Research Horizons, Oxford Science Enterprises, and University of Oxford have invested in Alethiomics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »